|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4245051A
(en)
|
1978-03-30 |
1981-01-13 |
Rockefeller University |
Human serum plasminogen activator
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4658830A
(en)
|
1984-08-08 |
1987-04-21 |
Survival Technology, Inc. |
Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
|
|
DE3515869A1
(de)
|
1985-05-03 |
1986-11-13 |
Bayer Ag, 5090 Leverkusen |
Verfahren zur herstellung optisch aktiver azolderivate
|
|
JPS62153224A
(ja)
|
1985-12-27 |
1987-07-08 |
Green Cross Corp:The |
プラスミノゲン製剤
|
|
GB8721951D0
(en)
|
1987-09-18 |
1987-10-28 |
Thrombosis Research Trust |
Organic compounds
|
|
JP2764264B2
(ja)
|
1987-10-01 |
1998-06-11 |
株式会社ミドリ十字 |
線溶活性増強剤
|
|
AT402367B
(de)
|
1990-10-11 |
1997-04-25 |
Immuno Ag |
Pharmazeutische zubereitung auf basis von lys-plasminogen
|
|
WO1994001128A1
(en)
*
|
1992-07-01 |
1994-01-20 |
Beth Israel Hospital Boston |
Enhancement of thrombolytic therapy with deglycosylated plasminogen
|
|
US5520912A
(en)
|
1993-07-02 |
1996-05-28 |
Immuno Aktiengesellschaft |
Prevention and treatment of ischemic events and reperfusion injury resulting therefrom using lys-plasminogen
|
|
DK125693D0
(enExample)
|
1993-11-05 |
1993-11-05 |
Novo Nordisk As |
|
|
DE4411143C2
(de)
|
1994-03-30 |
1996-08-01 |
Immuno Ag |
Thrombosemittel
|
|
CA2226575C
(en)
|
1995-07-27 |
2011-10-18 |
Genentech, Inc. |
Stabile isotonic lyophilized protein formulation
|
|
EP1001985A1
(en)
|
1997-06-26 |
2000-05-24 |
Karolinska Innovations AB |
Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo
|
|
US7317003B2
(en)
|
1998-09-04 |
2008-01-08 |
National University Of Singapore |
Small peptides having anti-angiogenic and endothelial cell inhibition activity
|
|
US6465424B1
(en)
|
1999-02-17 |
2002-10-15 |
Bristol-Myers Squibb Company |
Anti-angiogenic agent and method for inhibiting angiogenesis
|
|
WO2000049871A1
(en)
|
1999-02-24 |
2000-08-31 |
Henry Ford Health System |
An anti-angiogenic kringle protein and its mutants
|
|
US6899877B2
(en)
|
1999-03-09 |
2005-05-31 |
Minu, L.L.C. |
Process for generating plasmin in the vitreous of the eye and inducing separation of the posterior hyaloid from the retina
|
|
US7544500B2
(en)
|
1999-11-13 |
2009-06-09 |
Talecris Biotherapeutics, Inc. |
Process for the production of a reversibly inactive acidified plasmin composition
|
|
US6964764B2
(en)
|
1999-11-13 |
2005-11-15 |
Talecris Biotherapeutics, Inc. |
Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
|
|
US20020159992A1
(en)
|
2000-09-29 |
2002-10-31 |
Jack Henkin |
Antiangiogenic polypeptides and methods for inhibiting angiogenesis
|
|
WO2002040510A2
(en)
*
|
2000-11-02 |
2002-05-23 |
Bristol-Myers Squibb Company |
Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors
|
|
AU2002336959B2
(en)
|
2001-08-10 |
2006-07-13 |
Novartis Ag |
Peptides that bind to atherosclerotic lesions
|
|
US7067492B2
(en)
|
2001-09-06 |
2006-06-27 |
Omnio Ab |
Method of promoting healing of a tympanic membrane perforation
|
|
CN1408431A
(zh)
|
2001-09-21 |
2003-04-09 |
北京华兴生生物技术有限公司 |
治疗与新生血管生成相关疾病的基因工程药物
|
|
US7202066B2
(en)
|
2002-01-29 |
2007-04-10 |
Carrington Laboratories, Inc. |
Combination of a growth factor and a protease enzyme
|
|
MXPA04007585A
(es)
|
2002-02-06 |
2005-09-20 |
N Zyme Biotec Gmbh |
Metodo para la produccion de proteinas recombinantes en microorganismos.
|
|
US20050124036A1
(en)
*
|
2002-02-06 |
2005-06-09 |
Rudy Susilo |
Method for producing recombinant proteins in micro-organisms
|
|
US20030199464A1
(en)
|
2002-04-23 |
2003-10-23 |
Silviu Itescu |
Regeneration of endogenous myocardial tissue by induction of neovascularization
|
|
JP2006507297A
(ja)
|
2002-05-13 |
2006-03-02 |
チルドレンズ・ホスピタル・ロサンジェルス |
ケロイドおよび他の皮膚または内部創傷または病変における異常瘢痕形成の処置および予防
|
|
CN1668645A
(zh)
|
2002-05-17 |
2005-09-14 |
埃斯佩里安医疗公司 |
治疗缺血再灌注的方法和组合物
|
|
CN100446772C
(zh)
|
2002-12-06 |
2008-12-31 |
法布罗根股份有限公司 |
一种稳定HIFα的制剂在制备治疗糖尿病的药物中的应用
|
|
WO2004052856A1
(en)
|
2002-12-10 |
2004-06-24 |
Wyeth |
Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
|
|
CN1451746A
(zh)
|
2003-03-20 |
2003-10-29 |
广州市启源生物科技有限公司 |
人纤溶酶原Kringle 5缺失突变重组多肽
|
|
US20070276011A1
(en)
|
2003-09-11 |
2007-11-29 |
Susumu Muto |
Plasminogen Activator Inhibitor-1 Inhibitor
|
|
DE602004006437T2
(de)
|
2003-09-24 |
2008-01-10 |
Alstom Technology Ltd. |
Legierung zum löten und deren verwendung
|
|
JP4740531B2
(ja)
|
2003-09-30 |
2011-08-03 |
雪印乳業株式会社 |
骨吸収抑制剤
|
|
PL2246417T3
(pl)
|
2004-04-22 |
2015-06-30 |
Grifols Therapeutics Inc |
Rekombinacyjnie zmodyfikowana plazmina
|
|
US8357147B2
(en)
|
2005-08-17 |
2013-01-22 |
Spinal Restoration, Inc. |
Method for repairing intervertebral discs
|
|
FR2882654B1
(fr)
*
|
2005-03-01 |
2007-04-27 |
Servier Lab |
Utilisation de derives de la diosmetine pour le traitement et la prevention des pathologies thrombotiques
|
|
WO2006095713A1
(ja)
|
2005-03-08 |
2006-09-14 |
Institute Of Medicinal Molecular Design. Inc. |
プラスミノゲンアクチベータインヒビター－１阻害剤
|
|
WO2006102395A2
(en)
|
2005-03-22 |
2006-09-28 |
Medstar Health Inc |
Delivery systems and methods for diagnosing and treating cardiovascular diseases
|
|
US20060257391A1
(en)
|
2005-05-11 |
2006-11-16 |
Bausch & Lomb Incorporated |
Non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions
|
|
EP2000145A4
(en)
|
2006-03-24 |
2010-08-25 |
Rohto Pharma |
AGENT FOR ENHANCING METABOLIC SYNDROME
|
|
AU2007290882B2
(en)
|
2006-08-28 |
2013-02-21 |
Omnio Healer Ab |
Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
|
|
CA2662101C
(en)
|
2006-08-28 |
2015-07-07 |
Omnio Healer Ab |
Candidates against infection
|
|
CA2666670A1
(en)
|
2006-10-20 |
2008-05-02 |
Dow Global Technologies Inc. |
Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome
|
|
CN101219219B
(zh)
|
2007-01-10 |
2013-02-13 |
北京普罗吉生物科技发展有限公司 |
包含血管抑素或其片段的复合物、其制备方法及应用
|
|
CN101015686B
(zh)
|
2007-02-06 |
2010-05-19 |
中国人民解放军军事医学科学院基础医学研究所 |
一种溶栓药物增效剂及其制备方法
|
|
US20080200387A1
(en)
|
2007-02-15 |
2008-08-21 |
Hua-Lin Wu |
Anti-angiogenic protein, composition and use thereof
|
|
AR067446A1
(es)
|
2007-07-11 |
2009-10-14 |
Otsuka Pharma Co Ltd |
Un medicamento para tratar higado graso que comprende cilostazol
|
|
AT505574B1
(de)
*
|
2007-08-10 |
2009-09-15 |
Affiris Forschungs & Entwicklungs Gmbh |
Mimotope zur behandlung von atherosklerose
|
|
US20090239868A1
(en)
|
2007-10-23 |
2009-09-24 |
Institute Of Medical Molecular Design, Inc. |
Inhibitor of pai-1 production
|
|
WO2009054439A1
(ja)
|
2007-10-23 |
2009-04-30 |
Institute Of Medicinal Molecular Design, Inc. |
Pai-1産生抑制剤
|
|
US8101394B2
(en)
|
2007-11-29 |
2012-01-24 |
Grifols Therapeutics Inc. |
Recombinantly modified plasmin
|
|
US8431363B2
(en)
*
|
2008-01-09 |
2013-04-30 |
Intrexon Corporation |
Polynucleotides encoding therapeutic inhibitors of PAI-1
|
|
US20090208448A1
(en)
|
2008-02-15 |
2009-08-20 |
Solomon Keith R |
Inhibition of angiogenesis
|
|
WO2010076655A1
(en)
|
2008-12-30 |
2010-07-08 |
Ikfe Gmbh |
Biomarkers for adipose tissue activity
|
|
EP2389176A4
(en)
|
2009-01-23 |
2012-08-01 |
Univ Sydney |
NEW THERAPY FOR METABOLISM DISEASE
|
|
BRPI1013392A2
(pt)
|
2009-03-31 |
2016-03-29 |
Renascience Co Ltd |
inibidor do inibidor-1 do ativador do plasminogênio
|
|
EP2424561A2
(en)
|
2009-04-30 |
2012-03-07 |
Catherine Blondel |
Methods for treating ocular conditions
|
|
NZ597452A
(en)
*
|
2009-07-10 |
2013-10-25 |
Thrombogenics Nv |
Variants of plasminogen and plasmin
|
|
CA2770688C
(en)
|
2009-08-12 |
2018-06-05 |
Cornell University |
Methods for preventing or treating metabolic syndrome
|
|
CN101628113B
(zh)
|
2009-08-18 |
2012-01-04 |
南京农业大学 |
蚯蚓纤溶酶抗肝纤维化的应用
|
|
CN101897925B
(zh)
*
|
2009-12-16 |
2015-04-29 |
成都百康医药工业药理毒理研究院 |
一种治疗代谢综合症的药物组合物
|
|
US20120114652A1
(en)
|
2010-05-03 |
2012-05-10 |
Abbott Laboratories |
Anti-pai-1 antibodies and methods of use thereof
|
|
WO2012021287A2
(en)
*
|
2010-08-09 |
2012-02-16 |
The Johns Hopkins University |
Methods for the treatment and prevention of metabolic disorders
|
|
CN102121023B
(zh)
|
2010-12-22 |
2012-07-04 |
中山大学 |
突变型人纤溶酶原kringle5及其制备方法及应用
|
|
CA2823491A1
(en)
*
|
2011-01-05 |
2012-07-12 |
Thrombogenics Nv |
Plasminogen and plasmin variants
|
|
CN102154253A
(zh)
|
2011-01-06 |
2011-08-17 |
郑州大学 |
具有抑制血小板凝集功能的微小纤溶酶原突变体及其制备方法和用途
|
|
US9078904B2
(en)
*
|
2011-02-10 |
2015-07-14 |
Trustees Of Dartmouth College |
Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis
|
|
JP2014518609A
(ja)
|
2011-03-03 |
2014-08-07 |
テルサス ファーマシューティカルズ リミテッド ライアビリティ カンパニー |
Ｃ１６：１ｎ７−パルミトレアートを含む組成物および方法
|
|
CN102199587B
(zh)
|
2011-03-24 |
2013-06-19 |
广东药学院 |
人纤溶酶原功能性突变体及其制备方法和应用
|
|
CA2830375A1
(en)
|
2011-03-30 |
2012-10-04 |
Board Of Regents Of The University Of Texas System |
Methods and compositions for targeting adipose cells in mammals
|
|
CN102188699A
(zh)
|
2011-05-06 |
2011-09-21 |
南京农业大学 |
一种治疗动脉粥样硬化的药物组合物及其制备方法和应用
|
|
US20120058537A1
(en)
|
2011-07-27 |
2012-03-08 |
Fereidoun Mahboudi |
Chimeric truncated and mutant variant of tissue plasminogen activator (t-pa) resistant to plasminogen activator inhibitor-1
|
|
CA2844644A1
(en)
|
2011-08-12 |
2013-02-21 |
Thrombogenics N.V. |
Plasminogen and plasmin variants
|
|
CN102532326B
(zh)
|
2011-11-18 |
2017-06-09 |
南京大学 |
一种肿瘤靶向的人纤溶酶原Kringle5变体及其应用
|
|
CN103656630B
(zh)
|
2012-09-11 |
2015-07-08 |
江苏仁寿药业有限公司 |
一种提纯动物药材中纤溶酶并制备成中药组合物的方法
|
|
DK2914575T3
(da)
|
2012-10-31 |
2021-01-18 |
Univ Michigan Regents |
Plasminogen-aktivator-1-inhibitorer og fremgangsmåder til anvendelse deraf
|
|
WO2014160275A2
(en)
|
2013-03-14 |
2014-10-02 |
Battell Memorial Institute |
Biomarkers for liver fibrosis
|
|
TWI689490B
(zh)
|
2013-03-15 |
2020-04-01 |
英商邊緣生物科技有限公司 |
用於治療纖維化之經取代之芳族化合物及相關方法
|
|
CN105008320A
(zh)
*
|
2013-03-20 |
2015-10-28 |
埃莱万斯可再生能源科学股份有限公司 |
烷基酯和羧酸的酸催化低聚
|
|
CN104274449A
(zh)
|
2013-07-11 |
2015-01-14 |
无锡信达医疗器械有限公司 |
治疗肥胖症的药物组合物
|
|
TW201722994A
(zh)
|
2013-08-13 |
2017-07-01 |
賽諾菲公司 |
胞漿素原活化素抑制劑-１（ｐａｉ-１）之抗體及其用途
|
|
BR112016002753A2
(pt)
|
2013-08-13 |
2017-11-21 |
Sanofi Sa |
anticorpos contra o inibidor-1 de ativador de plasminogênio (pai-1) e usos dos mesmos
|
|
US20160199466A1
(en)
|
2013-08-20 |
2016-07-14 |
Trustees Of Dartmouth College |
Methods For Treating Tissue Fibrosis
|
|
PY1577621A
(es)
|
2014-12-19 |
2017-10-02 |
Prometic Biotherapeutics Inc |
Composicion farmaceutica que comprende plasminogeno y uso para el mismo
|
|
TWI801331B
(zh)
|
2015-11-03 |
2023-05-11 |
美商波麥堤克生物治療股份有限公司 |
纖維蛋白溶酶原缺乏症之纖維蛋白溶酶原替代療法
|
|
TWI653981B
(zh)
|
2015-12-18 |
2019-03-21 |
深圳瑞健生命科學硏究院有限公司 |
Use of plasminogen for the preparation of a medicament for preventing or treating a condition associated with diabetic nerve injury
|
|
WO2017101866A1
(zh)
|
2015-12-18 |
2017-06-22 |
深圳瑞健生命科学研究院有限公司 |
一种用于预防或治疗急性及慢性血栓的方法
|
|
JP2019500426A
(ja)
|
2015-12-18 |
2019-01-10 |
タレンゲン インターナショナル リミティッドＴａｌｅｎｇｅｎ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｌｉｍｉｔｅｄ |
糖尿病網膜症を予防または治療するための方法
|
|
TWI677347B
(zh)
|
2015-12-18 |
2019-11-21 |
大陸商深圳瑞健生命科學研究院有限公司 |
一種預防和治療肝組織損傷及其相關病症的方法
|
|
EP3395354B1
(en)
|
2015-12-18 |
2024-05-22 |
Talengen International Limited |
Plasminogen for use in treating diabetic nephropathy
|
|
WO2017101871A1
(zh)
|
2015-12-18 |
2017-06-22 |
深圳瑞健生命科学研究院有限公司 |
一种预防和治疗心血管病的新方法
|
|
TWI677348B
(zh)
|
2016-12-15 |
2019-11-21 |
大陸商深圳瑞健生命科學研究院有限公司 |
一種改善心臟病變的方法
|
|
JP7168990B2
(ja)
|
2016-12-15 |
2022-11-10 |
タレンゲン インターナショナル リミテッド |
肥満症を予防および治療するための方法および薬物
|
|
TWI750189B
(zh)
|
2016-12-15 |
2021-12-21 |
大陸商深圳瑞健生命科學研究院有限公司 |
一種治療冠狀動脈粥樣硬化及其併發症的方法
|
|
TWI868051B
(zh)
|
2017-06-23 |
2025-01-01 |
美商波麥堤克生物治療股份有限公司 |
與pai-1過表現相關之病狀的纖維蛋白溶酶原治療
|